Advertisement
Advertisement
CTEV
Claritev Corporation
22.71
USDSponsored
+2.49
+12.31%
Nov 06, 15:59 UTC -5
Closed
After-Market
22.75
+0.04
+0.18%
Claritev Corporation (CTEV) Earnings
CTEV Earnings Reports
Positive Surprise Ratio
CTEV beat 12 of 24 last estimates.
50%
Next Report
Tomorrow BMO
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$261.25M
/-$3.69
Implied change from Q2 26 (Revenue/ EPS)
+1.47%
/+5.73%
Implied change from Q3 25 (Revenue/ EPS)
+6.22%
/-12.77%
Claritev Corporation earnings per share and revenue
On Aug 07, 2026, CTEV reported earnings of -3.49 USD per share (EPS) for Q2 26, beating the estimate of -4.21 USD, resulting in a 17.12% surprise. Revenue reached 257.48 million, compared to an expected 249.71 million, with a 3.11% difference. The market reacted with a +21.42% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -3.69 USD, with revenue projected to reach 261.25 million USD, implying an increase of 5.73% EPS, and increase of 1.47% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enovis Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.78
Actual
$0.88
Surprise
+12.07%
Evolent Health, Inc Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.05
Actual
$0.06
Surprise
+13.21%
Fulgent Genetics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.66
Actual
-$0.09
Surprise
+86.43%
Health Catalyst, Inc Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.03
Surprise
+38.14%
CareCloud, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.11
Actual
$0.14
Surprise
+19.35%
10x Genomics, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.15
Surprise
+43.35%
Doximity, Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$0.35
Actual
$0.36
Surprise
+0.56%
iRhythm Holdings, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.06
Actual
$0.82
Surprise
+1,214.10%
Privia Health Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.09
Actual
$0.10
Surprise
+3.73%
Schrodinger, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.70
Actual
-$0.50
Surprise
+29.57%
FAQ
What were Claritev Corporation's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Claritev Corporation reported EPS of -$3.49, beating estimates by 17.12%, and revenue of $257.48M, 3.11% above expectations.
How did the market react to Claritev Corporation's Q2 2026 earnings?
The stock price moved up 21.42%, changed from $26.84 before the earnings release to $32.59 the day after.
When is Claritev Corporation expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Claritev Corporation's next earnings report?
Based on 3
analysts, Claritev Corporation is expected to report EPS of -$3.69 and revenue of $261.25M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.